Literature DB >> 8784649

The clinician and drug interactions--an update.

R I Shader, L L von Moltke, J Schmider, J S Harmatz, D J Greenblatt.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8784649     DOI： 10.1097/00004714-199606000-00001

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

Review 1.  Pharmacologic treatment of depression in late life.

Authors:  A J Flint
Journal:  CMAJ       Date:  1997-10-15       Impact factor: 8.262

2.  Venlafaxine drug-drug interactions in clinical practice.

Authors:  F Benazzi
Journal:  J Psychiatry Neurosci       Date:  1998-05       Impact factor: 6.186

Review 3.  Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness.

Authors:  S M Cheer; K L Goa
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 4.  Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence.

Authors:  B A Sproule; C A Naranjo; K E Brenmer; P C Hassan
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

Review 5.  Drug interactions of clinical significance with selective serotonin reuptake inhibitors.

Authors:  P B Mitchell
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.606

Review 6.  Choosing appropriate antidepressant therapy in the elderly. A risk-benefit assessment of available agents.

Authors:  A J Flint
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.